Report Code: A08422 | Pages: NA | Mar 2023 | 1507 Views | ||
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Diagnostic Specialty Antibodies Market
Request Now !Antibodies are blood protein. Every specific antigen has a specific antibody manufactured by the body. They are generally called immunoglobulin and are usually in the shape of the Y structure. Upgrades in technology, especially in the field of genetic engineering manufacture help to introduce various antibodies, which are usually monoclonal antibodies. These are additionally efficacious and robust, which help in the betterment of the capacity of binding to an antigen. Moreover, this has proven productive when diagnostics tool are considered for the evaluation of the disease. Furthermore, the demand for diagnostic specialty has decreased lately due to the issues faced regarding antibodies that are not able to run a proper and smooth diagnostic test for regular diagnosis and high cost of monoclonal antibodies.
COVID-19 scenario analysis:
There is significant rise in the demand for diagnostic specialty antibodies in the past few years, owing to the accurate diagnosis provided by the device for a variety of diseases. A major change in lifestyle and evolution has been observed, which makes the population much more prone to various infectious and diseases. These diseases have the ability to spread at a higher rate and impact a large portion of society. Therefore, these are the major factors propelling the growth of the diagnostic specialty antibodies market.
The devices used for the antibodies diagnosis are helping on a large scale in the identification and halting the spread of diseases ultimately. Along with this recent research and development activities which are helping development technologies in the diagnostic specialty antibodies market which has brought a revolution in the treatment and diagnosis field.
On April 12th, 2017, Roche introduced a new monoclonal antibody for the diagnosis of prostate cancer. On January 3rd, 2017, Multiplicom NV was acquired by Agilent Technology, which helped it widen its portfolio in molecular diagnostics. On January 3rd, 2017, Sanofi and Boehringer Ingelheim entered into an agreement.
Hospitals and diagnostic laboratories are the major consumers of the diagnostic specialty antibodies market. Amongst them, the hospitals are the biggest end-user of the market due to the rise in the diagnostic specialty antibody products and the R & D of distinctive antibodies that work automatically in the private hospitals and universities as well.
Hospitals are helping in the in-training health officials and spreading awareness in regards to the deficiency of primary antibody. This helps in the betterment of patient care and helps in creating new opportunities for better treatment in the primary immunodeficiency disorders.
Key benefits of the report:
Questions answered in the diagnostic specialty antibodies market research report:
Diagnostic Specialty Antibodies Market: Global Opportunity Analysis and Industry Forecast 2020–2027 Report Highlights
Aspects | Details |
---|---|
By Antibody Type |
|
By Application |
|
By End User |
|
By Region |
|
Key Market Players | F. Hoffmann-La Roche AG, Sanofi, Abbott Laboratories, Abcam plc, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Agilent Technologies, Inc., Aytu BioScience, Inc |
Loading Table Of Content...
Start reading.
This Report and over 19,603+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers